Aurora Cannabis Inc (NASDAQ:ACB) traded at $4.42 at close of the session on Monday, March 10 and made a downward move of -7.14% on its previous day’s price.
Aurora Cannabis Inc has a market cap of $242.57 million and is expected to release its quarterly earnings report in April.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at 88.85M, with a low of 87M and a high of 92.6M. The median projection represents growth squeezing down to 31.80% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for current year is expected to hit 342.24M, or 26.62% up from figures reported last year.
On the other hand, looking at the outlook for the ACB stock, short term indicators assign the stock an average of 50% Buy, while medium term indicators assign it an average of 100% Sell.
Based on estimates by 7 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 5 have rated the Aurora Cannabis Inc (ACB) stock as a Hold, while 2 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Hold and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is -20.59% off its SMA20 and -7.32% from its 50-day simple moving average. The RSI (14) is pointing at 38.47 while the volatility over the past week is 6.29% and jumps to 7.65% over the past one month. The beta value is 1.62, while the average true range (ATR) is currently pointing at 0.39. The average price target for the stock over the next 12 months is $8, with the estimates having a low of $1 and a high of $8.75322283. These price ends are 77.38% and -98.04% off the current price level respectively, although investors could be excited at the prospect of a -81.0% if the ACB share price touches on the median price of $8.
